|
1
|
Li JY, Zheng LW, Ma L, Kwong DL, Cheung LK
and Pow EH: Effect of fluoride-modified titanium surface on early
adhesion of irradiated osteoblasts. Biomed Res Int. 19752:2015.
|
|
2
|
Annibali S, Pranno N, Cristalli MP, La
Monaca G and Polimeni A: Survival analysis of implant in patients
with diabetes mellitus: A systematic review. Implant Dent.
25:663–674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang ND, Han T, Huang BK, Rahman K, Jiang
YP, Xu HT, Qin LP, Xin HL, Zhang QY and Li YM: Traditional Chinese
medicine formulas for the treatment of osteoporosis: Implication
for antiosteoporotic drug discovery. J Ethnopharmacol. 189:61–80.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang WD, Zhang C, Liu RH, Li HL, Zhang
JT, Mao C, Moran S and Chen CL: Preclinical pharmacokinetics and
tissue distribution of a natural cardioprotective agent
astragaloside IV in rats and dogs. Life Sci. 79:808–815. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu
JH, Zhang WD and Chen J: Astragaloside IV protects against ischemic
brain injury in a murine model of transient focal ischemia.
Neurosci Lett. 363:218–223. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang WJ, Hufnagl P, Binder BR and Wojta
J: Antiinflammatory activity of astragaloside IV is mediated by
inhibition of NF-kappaB activation and adhesion molecule
expression. Thromb Haemost. 90:904–914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang S, Tang D, Zang W, Yin G, Dai J, Sun
YU, Yang Z, Hoffman RM and Guo X: Synergistic inhibitory effect of
traditional Chinese medicine astragaloside IV and curcumin on tumor
growth and angiogenesis in an orthotopic nudemouse model of human
hepatocellular carcinoma. Anticancer Res. 37:465–473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang K, Lu Q, Li Q, Ji Y, Chen W and Xue
X: Astragaloside IV inhibits breast cancer cell invasion by
suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol.
42:195–202. 2017. View Article : Google Scholar
|
|
9
|
Xia B, Xu B, Sun Y, Xiao L, Pan J, Jin H
and Tong P: The effects of Liuwei Dihuang on canonical
Wnt/β-catenin signaling pathway in osteoporosis. J Ethnopharmacol.
153:133–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang SC, Kim HJ and Kim MH: Effects of
Astragalus membranaceus with supplemental calcium on bone mineral
density and bone metabolism in calcium-deficient ovariectomized
rats. Biol Trace Elem Res. 151:68–74. 2013. View Article : Google Scholar
|
|
11
|
Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J,
Zhang J, Li LH, Xia Y, Yao LB, Qin HZ and Gao GD: Astragaloside IV
prevents MPP+-induced SH-SY5Y cell death via the inhibition of
Bax-mediated pathways and ROS production. Mol Cell Biochem.
364:209–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Yu L, She T, Gan Y, Liu F, Hu Z,
Chen Y, Li S and Xia H: Astragaloside IV attenuates Toll-like
receptor 4 expression via NF-κB pathway under high glucose
condition in mesenchymal stem cells. Eur J Pharmacol. 696:203–209.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haiyan H, Rensong Y, Guoqin J, Xueli Z,
Huaying X and Yanwu X: Effect of Astragaloside IV on neural stem
cell transplantation in Alzheimer's disease rat models. Evid Based
Complemen. Alternat Med. 2016:31069802016.
|
|
14
|
Wang S, Chen J, Fu Y and Chen X: Promotion
of Astragaloside IV for EA-hy926 cell proliferation and angiogenic
activity via ERK1/2 pathway. J Nanosci Nanotechnol. 15:4239–4244.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie J, Wang H, Song T, Wang Z, Li F, Ma J,
Chen J, Nan Y, Yi H and Wang W: Tanshinone IIA and astragaloside IV
promote the migration of mesenchymal stem cells by up-regulation of
CXCR4. Protoplasma. 250:521–530. 2013. View Article : Google Scholar
|
|
16
|
Li M, Wang W, Geng L, Qin Y, Dong W, Zhang
X, Qin A and Zhang M: Inhibition of RANKL-induced
osteoclastogenesis through the suppression of the ERK signaling
pathway by astragaloside IV and attenuation of
titanium-particle-induced osteolysis. Int J Mol Med. 36:1335–1344.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alman BA: The role of hedgehog signaling
in skeletal health and disease. Nat Rev Rheumatol. 11:552–560.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemtland R, Divieti P, Lee K and Segre GV:
Hedgehog promotes primary osteoblast differentiation and increases
PTHrP mRNA expression and iPTHrP secretion. Bone. 32:611–620. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang J, Andre P, Ye L and Yang YZ: The
Hedgehog signalling pathway in bone formation. Int J Oral Sci.
7:73–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakamura T, Aikawa T, Iwamoto-Enomoto M,
Iwamoto M, Higuchi Y, Pacifici M, Kinto N, Yamaguchi A, Noji S,
Kurisu K, et al: Induction of osteogenic differentiation by
hedgehog proteins. Biochem Biophys Res Commun. 237:465–469. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enomoto-Iwamoto M, Nakamura T, Aikawa T,
Higuchi Y, Yuasa T, Yamaguchi A, Nohno T, Noji S, Matsuya T, Kurisu
K, et al: Hedgehog proteins stimulate chondrogenic cell
differentiation and cartilage formation. J Bone Miner Res.
15:1659–1668. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mas C and Ruiz i Altaba A: Small molecule
modulation of HH-GLI signaling: Current leads, trials and
tribulations. Biochem Pharmacol. 80:712–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thayer SP, di Magliano MP, Heiser PW,
Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del
Castillo C, Yajnik V, et al: Hedgehog is an early and late mediator
of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fukaya M, Isohata N, Ohta H, Aoyagi K,
Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto
H, et al: Hedgehog signal activation in gastric pit cell and in
diffuse-type gastric cancer. Gastroenterology. 131:14–29. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Olive KP, Jacobetz MA, Davidson CJ,
Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA,
Caldwell ME, Allard D, et al: Inhibition of Hedgehog signaling
enhances delivery of chemotherapy in a mouse model of pancreatic
cancer. Science. 324:1457–1461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bar EE, Chaudhry A, Lin A, Fan X, Schreck
K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, et al:
Cyclopamine mediated Hedgehog pathway inhibition depletes stem-like
cancer cells in glioblastoma. Stem Cells. 25:2524–2533. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Briscoe J and Thérond PP: The mechanisms
of Hedgehog signalling and its roles in development and disease.
Nat Rev Mol Cell Biol. 14:416–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Chen JK, Taipale J, Young KE, Maiti T and
Beachy PA: Small molecule modulation of Smoothened activity. Proc
Natl Acad Sci USA. 99:14071–14076. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karsenty G: The complexities of skeletal
biology. Nature. 423:316–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Von Wilmowsky C, Moest T, Nkenke E,
Stelzle F and Schlegel KA: Implants in bone: Part I. A current
overview about tissue response, surface modification sand future
perspectives. Oral Maxillofac Surg. 18:243–257. 2014. View Article : Google Scholar
|
|
33
|
Terheyden H, Lang NP, Bierbaum S and
Stadlinger B: Osseointegration-communication of cells. Clin Oral
Implants Res. 23:1127–1135. 2012. View Article : Google Scholar
|
|
34
|
Zhou R, Wei D, Cao J, Feng W, Cheng S, Du
Q, Li B, Wang Y, Jia D and Zhou Y: Synergistic effects of surface
chemistry and topologic structure from modified microarc oxidation
coatings on Ti implants for improving osseointegration. ACS Appl
Mater Interfaces. 7:8932–8941. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Andrukhov O, Huber R, Shi B, Berner S,
Rausch-Fan X, Moritz A, Spencer ND and Schedle A: Proliferation,
behavior, and differentiation of osteoblasts on surfaces of
different micro-roughness. Dent Mater. 32:1374–1384. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smeets R, Stadlinger B, Schwarz F,
Beck-Broichsitter B, Jung O, Precht C, Kloss F, Gröbe A, Heiland M
and Ebker T: Impact of dental implant surface modifications on
osseointegration. Biomed Res Int. 2016:62856202016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng X, Gu J, Zhang M, Yuan J, Zhao B,
Jiang J and Jia X: Astragaloside IV inhibits migration and invasion
in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB
pathway. Int Immunopharmacol. 23:304–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qin CD, Ma DN, Ren ZG, Zhu XD, Wang CH,
Wang YC, Ye BG, Cao MQ, Gao DM and Tang ZY: Astragaloside IV
inhibits metastasis in hepatoma cells through the suppression of
epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin
pathway. Oncol Rep. 37:1725–1735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li B, Wang F, Liu N, Shen W and Huang T:
Astragaloside IV inhibits progression of glioma via blocking
MAPK/ERK signaling pathway. Biochem Biophys Res Commun. 491:98–103.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sims NA and Gooi JH: Bone remodeling:
Multiple cellular interactions required for coupling of bone
formation and resorption. Semin Cell Dev Biol. 19:444–451. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Javed A, Bae JS, Afzal F, Gutierrez S,
Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS and
Lian JB: Structural coupling of Smad and Runx2 for execution of the
BMP2 osteogenic signal. J Biol Chem. 283:8412–8422. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Baron R and Kneissel M: WNT signaling in
bone homeostasis and disease: From human mutations to treatments.
Nat Med. 19:179–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li MJ, Li F, Xu J, Liu YD, Hu T and Chen
JT: rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and
NF-κB-dependent manner. Biosci Rep. 36:e003002016. View Article : Google Scholar
|
|
44
|
Horikiri Y, Shimo T, Kurio N, Okui T,
Matsumoto K, Iwamoto M and Sasaki A: Sonic hedgehog regulates
osteoblast function by focal adhesion kinase signaling in the
process of fracture healing. PLoS One. 8:e767852013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kimura H, Ng JM and Curran T: Transient
inhibition of the Hedgehog pathway in young mice causes permanent
defects in bone structure. Cancer Cell. 13:249–260. 2008.
View Article : Google Scholar : PubMed/NCBI
|
